3rd place in MedImmune’s European Cancer Research Awards

Thomas R. Cox, Nov 2010

Today MedImmune announced the winners of its second annual European Cancer Research competition which highlights the research of the next generation of scientific leaders in cancer research.

Students and postdoctoral fellows from across Europe were invited to submit abstracts describing their research in the field of tumour microenvironments as part of the competition sponsored by MedImmune, AstraZeneca’s global biologics unit, which has a research facility in Cambridge, the United Kingdom.

First prize was awarded to Carmela De Santo from The Weatherall Institute of Molecular Medicine, University of Oxford, UK for her project titled ‘A novel melanoma immunoescape mechanism based on the secretion of serum amyloid A and differentiation of IL-10-secreting neutrophils’. Second and third prizes were awarded to Alexandre Trindade from the Faculty of Veterinary Medicine, Technical University of Lisbon (UTL), Lisbon, Portugal and Gulbenkian Institute of Science, Oeiras, Portugal for his research in angiogenesis, and Thomas R. Cox from The Institute of Cancer Research (ICR), London, UK for his research into extracellular matrix modulation of metastasis respectively.

The competition was open to graduate students and postdoctoral fellows in Europe with ten finalists shortlisted to present their research to an expert panel of judges including Professor Adrian Harris, Weatherall Institute of Molecular Medicine, University of Oxford, UK; Dr. Christian Blank, Group Leader, Immunology, The Netherlands Cancer Institute, The Netherlands; Dr. Klaus Bosslet, Vice President Research, Oncology, MedImmune and Dr. Scott Hammond, Senior Scientist, Oncology, MedImmune.

The focus of the competition – tumour microenvironments – reflects the research interests of MedImmune’s UK-based Oncology Department in Cambridge. The three winners were announced at the awards ceremony at Cambridge University’s prestigious Downing College following evaluation of their presentations on the basis of scientific merit, innovation and delivery.


MedImmune Press Release
European Association for Cancer Research (EACR) Press Release